AJANTA PHARMA LTD. - Statement Of Investors Complaints For The Quarter Ended 31St March, 2017.

Pursuant to Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Statement of Investor Complaints for the quarter ended on 31st March, 2017 is submitted to the Stock Exchanges.